NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 30, 2024 was $19M, a 23.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $19M +$3.6M +23.3% Dec 30, 2024 10-K 2024-12-17
Q4 2023 $15.4M +$3.51M +29.5% Dec 30, 2023 10-K 2024-12-17
Q4 2022 $11.9M Dec 30, 2022 10-K 2023-12-15
Q3 2022 $11.9M +$3.11M +35.3% Sep 30, 2022 10-K 2022-12-22
Q3 2021 $8.81M +$3.11M +54.7% Sep 30, 2021 10-K 2022-12-22
Q3 2020 $5.69M +$1.74M +44.1% Sep 30, 2020 10-K/A 2022-05-31
Q3 2019 $3.95M +$1.84M +86.8% Sep 30, 2019 10-K 2020-12-09
Q3 2018 $2.12M Sep 30, 2018 10-K 2019-12-20
Q4 2017 $1.11M +$1M +943% Dec 31, 2017 10-KT/A 2019-03-18
Q4 2016 $106K +$43K +68.3% Dec 31, 2016 10-K 2018-04-16
Q4 2015 $63K +$17.3K +37.9% Dec 31, 2015 10-K 2017-04-17
Q4 2014 $45.7K +$14.1K +44.8% Dec 31, 2014 10-K 2016-04-14
Q4 2013 $31.6K Dec 31, 2013 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.